340B Drug Pricing Program
On Nov. 1, the CMS released the calendar year 2018 outpatient prospective payment system/ambulatory surgical center final rule.
The Centers for Medicare & Medicaid Services today announced it will update the hospital outpatient prospective payment system rates by 1.35% in calendar year 2018 compared to CY 2017. The rule also finalizes CMS鈥檚 proposal to drastically cut Medicare payment for drugs that are acquired鈥
CMS鈥檚 decision in today鈥檚 rule to cut Medicare payments to hospitals for drugs covered under the 340B program will dramatically threaten access to health care for many patients, including uninsured and other vulnerable populations. It is not based on sound policy and punishes hospitals and patients鈥
The Health Resources and Services Administration has announced that 340B Drug Pricing Program hospitals in areas affected by recent natural disasters can immediately enroll in the program instead of waiting for the normal registration period. 鈥淗RSA recognizes that circumstances surrounding disaster鈥
The House Energy and Commerce Subcommittee on Oversight and Investigations today held a hearing examining how covered entities use the 340B Drug Pricing Program. Established by Congress in 1992, the program mandates that drug manufacturers provide outpatient drugs to eligible health care鈥
The latest report from a group financed and backed by the pharmaceutical industry 鈥渃ontinues to misrepresent鈥 the 340B Drug Pricing Program and its 鈥渟uccessful 25-year history of helping hospitals stretch scarce financial resources to expand and improve access to lifesaving prescription drugs and鈥
The latest report from AIR340B, a group financed and backed by the pharmaceutical industry, continues to misrepresent a program with a successful 25-year history of helping hospitals stretch scarce financial resources to expand and improve access to lifesaving prescription drugs and comprehensive鈥
Fifty-seven senators Friday urged the Centers for Medicare & Medicaid Services (CMS) to 鈥渃arefully consider stakeholder feedback鈥 before the agency finalizes its proposal to reduce Medicare Part B payment for drugs acquired through the 340B Drug Pricing Program. 鈥淭he long-term success of the鈥
Fifty-seven senators Friday urged the Centers for Medicare & Medicaid Services to 鈥渃arefully consider stakeholder feedback" before the agency finalizes its proposal to reduce Medicare Part B payment for drugs acquired through the 340B Drug Pricing Program. "The long-term success of the 340B鈥
The 340B Drug Pricing Program 鈥渉as enabled hospitals and health systems to support and expand access and services consistent with their mission and the program鈥檚 original and ongoing charge,鈥 the AHA and Association of American Medical Colleges today told leaders of the House Energy and Commerce鈥